Hyderabad: Telangana IT and Industry Minister D Sridhar Babu on Tuesday said the State government aims to attract USD 25 billion in investments in the life sciences sector by 2035, create five lakh new jobs for youth, and position Telangana among the top three life sciences clusters in the world.
Talking to the media on the sidelines of the 23rd edition of BioAsia 2026, organised by the Telangana Government, the Minister said industrialists and representatives of research institutions participated with great enthusiasm in the conference, reflecting strong global confidence in Telangana’s life sciences ecosystem.
He said the vision of BioAsia is aligned with ongoing global economic, political and technological changes, and stressed that life sciences companies must increasingly adopt artificial intelligence and advanced technologies to remain globally competitive.
Sridhar Babu said the government’s core objective is to make healthcare accessible and affordable to the common people, while simultaneously developing Telangana as a global hub for life sciences and pharmaceuticals. He said the Telangana Life Sciences Policy is aimed at attracting investments worth USD 25 billion and building a robust, innovation-driven ecosystem.
The Minister announced that the State government is in the process of setting up a dedicated Life Sciences University and expanding Genome Valley Phase-IV over 100 acres with state-of-the-art infrastructure.
Referring to recent investment commitments, he said global healthcare major Opella from France has come forward with new investments, while US-based Trident AI has signed an agreement to invest Rs 300 crore.
He added that Rx Propellant has proposed investments of Rs 1,000 crore and several other companies have expressed interest in investing in the State, which would significantly boost employment opportunities.
The Minister also dismissed misinformation being spread by some quarters discouraging investments, stating that such narratives are baseless. He said Chief Minister A Revanth Reddy has congratulated Novartis for completing two decades of operations and services in Hyderabad, highlighting the city’s long-standing global partnerships.
Highlighting human capital development, Sridhar Babu said skill training for youth in emerging areas such as AI-based drug discovery is being undertaken through institutions like the Telangana School of Life Sciences and Young India Skills University to create a ready-to-work workforce.
He further said Hyderabad is evolving beyond manufacturing into a global centre for new drug research and innovation, and cited the CBRE Global Life Sciences Atlas 2025, which places Hyderabad alongside leading global hubs, underscoring the city’s growing international stature in life sciences research and development
